JD Bio Co., Ltd. Participates in the 7th Asia Pacific Anti-Aging Conference 2024 in Daegu
Global beauty and medical group JD Bio Co., Ltd. garnered significant attention by participating in the 7th Asia Pacific Anti-Aging Conference (APAAC 2024), held in Daegu from November 29 to December 1, 2024.
The conference brought together over 800 experts and business leaders from 15 countries, showcasing the latest technologies and products in medical skincare, including dermatology, plastic surgery, hair transplantation, and stem cell therapy—fields in which Daegu has a competitive edge. It was highly regarded as a platform for sharing innovative achievements in the beauty and medical industries while fostering collaboration and development within the sector.
At the event, JD Bio introduced its diverse product lineup, including the globally recognized One Tox®, premium RedTox®, and next-generation ExTox® botulinum toxin type A products. These offerings, underpinned by advanced technology and distinctive product capabilities, drew considerable interest from attendees and industry experts, culminating in a successful exhibition.
A JD Bio representative stated, "Through continuous research and development, we aim to present a new paradigm in the beauty and medical industry and lead the global market."
APAAC 2024 will be remembered as an event that demonstrated the potential for further growth in the anti-aging industry across the Asia-Pacific region through the fusion of medical and beauty technologies.
